News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hospira, Inc. (HSP) Hosts Conference Call For Third-Quarter Earnings



10/19/2005 5:11:48 PM

LAKE FOREST, Ill., Oct. 11 /PRNewswire-FirstCall/ -- Hospira, Inc. , the independent company recently created from the core global hospital products business of Abbott Laboratories, announced today that it will release its 2004 third-quarter financial results on Tuesday, Nov. 9, 2004, before the U.S. stock market opens. A conference call featuring remarks by senior management will be held with investors and the media that same day at 9 a.m. Central Time.

A live webcast of the conference call will be available online at http://www.hospira.com/ or through CCBN's individual investor center at http://www.companyboardroom.com/ . Listeners should log on approximately 10 minutes in advance to ensure proper computer setup to receive the webcast. A replay will be available for 30 days following the call.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM) by developing, manufacturing and marketing products that help improve the safety and efficacy of patient care. Created from the core global hospital products business of Abbott Laboratories, Hospira is a new company with 70 years of service to the hospital industry. The company's portfolio includes one of the industry's broadest lines of generic acute-care injectables, integrated solutions for medication management and infusion therapy, and a full-service contract manufacturing business. Headquartered in Lake Forest, Ill., north of Chicago, Hospira has more than 14,000 employees and 15 manufacturing facilities worldwide. Hospira's news releases and other information can be found at http://www.hospira.com/ .

Private Securities Litigation Reform Act of 1995 -- A Caution Concerning Forward-Looking Statements

Some statements in this news release may be forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. Hospira cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Economic, competitive, governmental, technological and other factors that may affect Hospira's operations and may cause actual results to be materially different from expectations include the risks and uncertainties set forth in the information statement under the heading "Risk Factors" in the most recent version of the Form 10 filed with the Securities and Exchange Commission, which are incorporated by reference. Hospira undertakes no obligation to release publicly any revisions to forward-looking statements as the result of subsequent events or developments.

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20040503/HSPLOGOAP Archive: http://photoarchive.ap.org/PRN Photo Desk, photodesk@prnewswire.comHospira, Inc.

CONTACT: Media, Stacey Eisen, +1-224-212-2276, or Financial Community,Lynn McHugh, +1-224-212-2363, both of Hospira, Inc.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES